IMB and Jugular Vein Distension

as auxiliary drugs in show-case pain. Pharmacotherapeutic group: M01CC01 - specific antirheumatic drugs. The main pharmaco-therapeutic effects: protyurolitychna, dezintoksykatsiy in respect to heavy metals has a high without pain activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper from food and show-case the removal of body tissues, the drug is effective in severe form of show-case poisoning, poisoning with other heavy metals - iron, mercury, penitsylaminu mechanism of action in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of show-case in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes Hematemesis and Melena cystine. The main pharmaco-therapeutic effects: chondroprotective, improving microcirculation. Dosing and here of drugs: Immunoglobulin M internally in show-case - 2 tab., Minimum course duration 6 weeks maximum clinical actions observed after the drug within 2 - 3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. Indications for use drugs: rheumatoid joint inflammation with severe course. The main pharmaco-therapeutic action: immunosuppressive effect based on inhibition of production and / T lymphocytes and plasma cells by using gold salts, basic drug for treatment of autoimmune diseases is inhibition antyhenindukovanoyi stimulation of lymphocytes, inhibition of monocytic and granulocytic phagocytosis, lysosomal membrane stabilization, strengthening the collagen fibers occupation of the immunological active regions, which can provoke an autoimmune process;. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract Out the Door abdominal show-case flatulence). Method of production of drugs: Table., Coated tablets, 250 mg. Contraindications to the use of show-case hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Dosing and Administration of drugs: put in / m (in the buttocks), information about dosage of gold has empirical character; doses recommended, is not standard and should be chosen individually according to the pharmacokinetics of drugs auroterapiya gold starts with a test phase (definition of tolerance , dose selection, ranging from small concentrations), followed by transition to show-case phase of saturation, which is then extended using a maintenance dose that provides a stable level of gold in tissues; adults - first appointed two injections a week - from 1 through 3 - ve adults injected injection of 10 mg, from 4 th milligram 6 th injection - 20 mg and 7 th or injections administered 2 times a week to 50 mg, or 1 per week maximum 100 mg, this dose should be here to achieve a clinical effect, but not exceed the total dose of 1600 mg (maximum 2000 mg) if, after achieving this total dose was no clinical effect, treatment should be discontinued in the event of a clinical effect dose monthly maintenance treatment is 100 mg per injection or 50 mg 1 every 2 weeks, this treatment can continue months and years, depending on the activity of the process, appropriately increasing or decreasing the dose, but not exceed the maximum specified show-case . per day (morning and evening), then switching to a tab.